Loading clinical trials...
Loading clinical trials...
The injury and wound conditions of the enrolled patients will be documented. A follow-up at 90 days post-administration will determine the clinical outcome of tetanus prophylaxis, specifically whether...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Zhuhai Trinomab Pharmaceutical Co., Ltd.
NCT07203755 · Diphtheria, Tetanus and Acellular Pertussis, Epidemic Meningitis, and more
NCT07112144 · Prevent Whooping Cough, Prevent Diphtheria, and more
NCT06947499 · Diphtheria, Tetanus, and more
NCT06635798 · Tetanus
NCT07149454 · Tetanus
The Second Affiliated Hospital of Shantou University
Shantou, Guangdong
Xiangyun County People's Hospital
Xiangyun, Yunnan
Shaoxing Central Hospital
Shaoxing, Zhejiang
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions